Institute for Molecular Design     About the IMD


        The Institute for Molecular Design is an educational and research center that focuses on bridging the theoretical and experimental approaches to biomolecular structure and function. This is an area of rapidly increasing importance in medicine and industry, in part because extraordinary advances in computing now make it possible to do accurate theoretical and experimental studies of enzymes, nucleic acids, and biomolecular assemblies.

         Founded in 1987, the IMD is the oldest U.S. center of its kind, equipped with state-of-the-art instruments for parallel supercomputing, computer graphics, X-ray crystallography, and NMR spectroscopy. Graduate students and postdoctoral associates enjoy unique opportunities for interdisciplinary research through collaborative research projects within the University of Houston and with the Texas Medical Center. In one project, new drugs are being designed by computer simulations based on X-ray structures of enzymes. Because of the broad importance of this work, the IMD is generously supported by government agencies, private foundations, and industry.

    Facts:
     

                         

    IMD Research Initiatives

    Pharmaceutical

        The IMD develops genetic medication targeted against cancer, developmental diseases and viral and bacterial infections.  Its scientists contribute to the development of drugs used in the treatment of cancer, heart disease, hypertension, polio, AIDS, diabetes mellitus, Alzheimer’s disease, and leukemia.  Among the IMD’s current objectives are to characterize and evaluate certain naturally-occurring pharmaceutical agents and design substitutes.
     

    Medicinal

    The IMD’s scientists:

    Industrial applications of IMD work include:
     

     

    IMD Educational Mission

        The IMD is committed to the educational development of its scientists and students.  Recognizing that future generations of scientists will benefit from knowledge of its technologies, the IMD:
     

     
     

Return to IMD homepage

 

Rev 4.0: By mp.